The EGFR pathway promotes the differentiation of stem cell-derived progenitors into mature gut cells during the regeneration and cell renewal of the planarian Schmidtea mediterranea. 
Introduction
shortening of the primary branch. Our data thus indicate that while control animals were capable of maintaining their gut morphology over time, egfr-1(RNAi) animals were unable to preserve the integrity of the gut, as evidenced by the gradual shortening of this structure and the loss of gut branches.
egfr-1 silencing affects gastrodermis integrity
The planarian gastrodermis is a monostratified epithelium composed of 2 cell types, absorptive phagocytes and secretory goblet cells, surrounded by an enteric muscular plexus (Bowen et al., 1974; Bueno et al., 1997; Kobayashi et al., 1998) . To better characterize the loss of the gut after egfr-1 RNAi, we performed a detailed histological analysis of the gastrodermis. Specifically, we studied intact egfr-1(RNAi) animals that were fixed 4 weeks after the last RNAi injection, the earliest time point at which all the features of the egfr-1 phenotype were evident (Fig. 3) . As observed in representative transverse sections corresponding to 4 different positions along the antero-posterior axis of the planarian body, egfr-1(RNAi) animals had fewer and smaller gut diverticula per section than controls (Fig. 4A) . Importantly, the defects in the gastrodermis in egfr-1(RNAi) animals were not correlated with loss of the enteric musculature surrounding the diverticula (anti-MHC) (Cebrià et al. 1997) , which appeared to be unaffected (Fig.   4A ). Moreover, Mallory's staining in sagittal sections revealed a reduced and aberrant gastrodermis in egfr-1(RNAi) animals, without the characteristic columnar disposition of cells evident in control animals (Fig. 4B ).
To support our qualitative observations, we performed quantitative analyses of the area of the gastrodermis in anterior and posterior sections of control and egfr-1(RNAi) animals (Fig. 4C) . Consistently, egfr-1 RNAi resulted in a significant decrease in the gastrodermal area in both regions (Fig. 4D) . Quantification of the number of nuclei per Development • Advance article diverticulum showed that the gastrodermis of egfr-1(RNAi) animals contained fewer nuclei than that of controls. However the number of nuclei relative to the area of the diverticulum remained constant, as this area was also significantly reduced in egfr-1(RNAi) animals (Fig. 4E) . To determine whether cell loss affected one or both gastrodermal cell types, we used the antibody RPZ-1 to specifically label goblet cells (Reuter et al., 2015) (Fig. 4F) . Immunostaining of anterior and posterior sections revealed a significant reduction in the number of goblet cells in egfr-1(RNAi) animals as compared with controls ( Fig. 4F, G ). As observed with Mallory's staining, the goblet cells of egfr-1(RNAi) animals showed abnormal morphologies (Fig. 4F) . We estimated the number of phagocytes by subtracting the number of goblet cells from the total number of gastrodermal cells as identified using the nuclear marker DAPI. The gastrodermis of egfr-1(RNAi) animals contained fewer phagocytes than that of controls, although the number of phagocytes relative to the area of the diverticulum remained constant in both control and egfr-1(RNAi) animals (Fig. 4H) ). Together, these results indicate that the morphological defects observed in egfr-1(RNAi) animals involve a reduction in gastrodermis area and depletion of both gastrodermal cell types.
Impaired gut progenitor cell differentiation accounts for the loss of gastrodermis in egfr-1(RNAi) animals
To determine whether the decrease in the number of cells in the gastrodermis of egfr-1(RNAi) animals was due to increased apoptosis, we performed TUNEL assays to quantify apoptotic cells (Pellettieri et al., 2010) in transverse sections of intact animals after egfr-1 RNAi (Fig. 5A) . egfr-1 RNAi resulted in a significant increase in the number of apoptotic mesenchymal cells (Fig. 5B) . However, there were no significant differences in the number of apoptotic gastrodermal cells between control and egfrDevelopment • Advance article 1(RNAi) animals ( Fig. 5C ), suggesting that the decrease in cell number seen in RNAi animals was not caused by an abnormal increase in apoptosis within this tissue.
We next investigated whether impaired differentiation of new cells could explain the defects seen after egfr-1 RNAi. To test this hypothesis we labeled S-phase neoblasts using the thymidine analog F-ara-EdU in control and egfr-1(RNAi) animals (Zhu et al., 2015) . After a 6-day chase, the presence of EdU-labeled cells was assessed in histological sections (Fig. 5D ). While control animals showed EdU-labeled cells within the gastrodermis, almost no EdU incorporation was observed in the gut tissue of egfr-1(RNAi) animals ( Silencing of the putative ligand nrg-1 phenocopies the defects observed in egfr-
1(RNAi) animals
To date, only 1 putative EGF ligand, epiregulin-1, has been identified in planarians. Its expression is limited to the digestive system (Wenemoser et al., 2012) (Fig. S2A ) and its silencing failed to affect gut regeneration or homeostasis (Fig. S2B) . We thus performed new in silico searches and identified a new putative EGF ligand, which we named nrg-1 (Fig. S3 ) (Barberán et al., 2016) . In intact animals, nrg-1 was mainly expressed in the mesenchyme and pharynx (Fig. 7A ). During regeneration, nrg-1 was expressed within blastemas from 3 days onwards, as well as in the mesenchyme and the newly regenerating pharynx (Fig. 7A) . nrg-1 RNAi affected both regeneration (Fig.7B , C) and homeostasis ( Fig. 7D-G (Fig. 7C) .
Furthermore, an increase in the neoblast population was observed in regenerating nrg-1(RNAi) animals (Fig. 7C ).
During homeostasis, nrg-1 RNAi led to a reduction in the number of eye pigment cells (Fig. 7D) , although the pharynx appeared unaffected (Fig. 7E) . We also observed fewer gut branches in nrg-1(RNAi) animals as compared with controls ( Fig. 7E ), although these defects were milder than those seen in the pre-existing tissue of regenerating animals ( Fig. 7C) . Finally, as in regenerating animals, the neoblast population was increased ( Fig. 7E-G) . Two rounds of dsRNA injection in both regenerating (Fig. S4A) and homeostatic animals ( Fig. S4B ) led to more severe defects in the pharynx, eyes, and gut, and ultimately to death of the animal after a few days. Our functional analyses revealed that nrg-1(RNAi) animals exhibit a phenotype strikingly similar to that of egfr-1(RNAi) animals, supporting the view that nrg-1 may act via egfr-1.
If nrg-1 does indeed activate egfr-1, a reduction in gut cell differentiation and an increase of the pool of gut progenitors (-neoblasts) would be expected after nrg-1 silencing. To investigate this hypothesis, we labeled S-phase neoblasts in control and nrg-1(RNAi) animals 20 days after a single round of dsRNA injection. After a 6-day chase, we observed a significant reduction of EdU incorporation in the gut tissue of nrg-1(RNAi) animals as compared with controls (Fig. 8A, B) . By contrast, no significant differences in the number of mesenchymal EdU-labeled cells were observed (Fig. 8C ).
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Next we assessed the -neoblast population by quantifying the number of animals ( Fig. 8D-I ). As predicted, nrg-1 silencing resulted in a significant increase in the number of hnf4 + /SMEDWI-1 + cells (Fig. 8D-E, H) . However, no significant differences in the number of gata4/5/6 + /SMEDWI-1 + cells (Fig. 8F-G, I ) were observed, likely because the gut defects were less severe after only one round of nrg-1 inhibition.
Overall, these results suggest that the gut defects observed in nrg-1(RNAi) animals are due to impaired differentiation of neoblasts into gastrodermal cells, further supporting our hypothesis that the putative EGF ligand nrg-1 controls differentiation of gut progenitors via egfr-1.
egfr-1 and nrg-1 silencing induces an increase in the expression of -and -neoblast markers, but exclusively affects gastrodermal cell differentiation
To elucidate how the general increase in the neoblast population in egfr-1(RNAi) and nrg-1(RNAi) animals affected the primary neoblast subclasses  and , we performed whole-mount in situ hybridizations with the  marker soxP-2 and the marker zfp-1 (van Wolfswinkel et al., 2014) . We observed an apparent increase in both neoblast subclasses in egfr-1(RNAi) and nrg-1(RNAi) animals (Fig. S5A, D) . qPCR analysis of soxP-2 and zfp-1 expression levels revealed a significant increase in the expression of both -and -class neoblasts in egfr-1 (RNAi) animals (Fig. S5B, C) , but only in -class neoblasts in nrg-1(RNAi) animals (Fig. S5E, F ). These results demonstrate that the expansion of the neoblast population observed after egfr-1 and nrg-1 silencing affects all described primary neoblast subclasses.
To determine whether this expansion of the neoblast population affected other cell lineages, we analyzed a set of known markers of differentiated cells and progenitor cells Development • Advance article from diverse planarian tissues. We observed no significant differences in the populations of dopaminergic (th) (Nishimura et al., 2007) or octopaminergic (tbh) (Nishimura et al., 2008) neurons between control and egfr-1(RNAi) animals ( Fig. S6A-C) , and no change in the expression of the neural progenitor marker coe (Cowles et al., 2013) (Fig. S6A) . Analysis of the expression of the protonephridial cell marker CAVII-1 (Sanchez Alvarado et al., 2002) and the excretory system progenitor marker pou2/3
(Scimone et al., 2011) revealed no differences between control and egfr-1(RNAi) animals ( Fig. S6D, E) . Similarly, expression of the epithelial lineage-specific marker AGAT-1 (Eisenhoffer et al., 2008; Tu et al., 2015) did not differ significantly between control and egfr-1(RNAi) animals (Fig. S6F, G) . Similar results were obtained after nrg-1 silencing (Fig. S7) . Altogether, these data suggest that the observed expansion of the neoblast population seen after both egfr-1 and nrg-1 RNAi does not affect the commitment/differentiation of neural, epidermal, or excretory cell lineages.
Finally, because pharynx regeneration and maintenance is also impaired in egfr-1 and nrg-1 RNAi animals (Fraguas et al., 2011), we sought to determine whether those alterations were attributable to an impaired differentiation of new pharyngeal cells. Both egfr-1 and nrg-1(RNAi) animals showed statistically similar numbers of EdU + cells within this organ (Fig. S8A-D) . Analysis of the expression of the pharynx-progenitor marker foxA (Adler et al., 2014) showed no significant differences between treated animals and controls (Fig. S8E, F) . Taken together, these results suggest that egfr-1 and nrg-1 are implicated in pharynx regeneration and homeostasis via a mechanism other than neoblast differentiation. Our results indicate that egfr-1 and nrg-1 are essential regulators of the differentiation of gut progenitors into mature gastrodermal cells. Remarkably, the specification of gut Development • Advance article progenitors (-neoblasts) is not affected after egfr-1 and nrg-1 silencing, and the expansion of this population is likely due to their incapacity to differentiate. This phenomenon is reminiscent of the phenotype observed after egr-5 silencing, whereby epidermal differentiation is impaired while numbers of epidermal progenitors increase (Tu et al., 2015) . Importantly, the analysis of other differentiated cell/progenitor populations, including epidermal, excretory, neural, and pharyngeal cells suggests that the silencing of egfr-1 and nrg-1 specifically affects differentiation of the gut lineage.
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We thus propose that in normal conditions, pluripotent neoblasts commit to gut progenitors and start expressing hnf4 and/or gata4/5/6, together with egfr-1. Upon nrg-1 binding, these cells proceed to differentiate into mature gut cells (Fig. 9A) . Silencing of either egfr-1 or its putative ligand nrg-1 disrupts EGFR signaling, and hence the differentiation of gut progenitors, leading to their accumulation in the mesenchyme (Fig. 9B) . However, several aspects of this scenario require further study such as the cellular origin of nrg-1, the dynamics of nrg-1/egfr-1 binding, and the mechanisms underlying nrg-1 proteolysis and diffusion. Finally, the EGF receptors egfr-3 and egfr-5
control the regeneration and homeostasis of particular planarian cell types, such as neuronal and excretory cells (Fraguas et al., 2011; Rink et al., 2011) . Further studies will thus help elucidate whether the model proposed here can be extrapolated to these other receptors, eventually uncovering a general role of the planarian EGFR pathway in the regulation of progenitor cell differentiation.
Strikingly, the silencing of egfr-1 and nrg-1 also results in the hyperproliferation and expansion of the -and -classes of neoblasts. However, this neoblast expansion does not appear to correlate with an increase in the number of differentiated cells of any of the cell lineages examined. One possibility is that the loss of gut tissue stimulates
